ResMed Inc. (RMD) Balance Sheet
RMD balance sheet, FY2026
June 30, 2026 · U.S. dollars$8.97B assets = $2.38B liabilities + $6.59B equity
Both columns are drawn to the same scale: what RMD owns equals what it owes plus shareholders’ equity. Hover a block for its value.
RMD financial health
Current ratio3.10
Comfortable · current assets cover current liabilities 3.10×
Debt / equity0.13
Low leverage · $0.13 of debt for each $1 of equity
Equity / assets73.4%
Equity-funded · of assets funded by shareholders
Cash / debt177.9%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles42.6%
Acquisition-heavy · of total assets
Descriptive bands, not a rating. Fiscal FY2026.
RMD balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $3.47BFY2017 | $8.97BFY2026 | +11.1%/yr | |
| Total liabilities | $1.51BFY2017 | $2.38BFY2026 | +5.2%/yr | |
| Shareholders’ equity | $1.96BFY2017 | $6.59BFY2026 | +14.4%/yr | |
| Cash & short-term investments | $821.9MFY2017 | $1.47BFY2026 | +6.7%/yr | |
| Total debt | $1.29BFY2017 | $825.9MFY2026 | −4.9%/yr | |
| Net cash (debt) | −$471.7MFY2017 | $643.3MFY2026 | +$1.1B | |
| Working capital | $1.28BFY2017 | $2.93BFY2026 | +$1.6B | |
| Book value per share | $13.76FY2017 | $45.09FY2026 | +14.1%/yr | |
| Current ratio | 4.57FY2017 | 3.10FY2026 | −1.47 | |
| Debt / equity | 0.66FY2017 | 0.13FY2026 | −0.53 | |
| Shares outstanding | 142.5MFY2017 | 146.1MFY2026 | +0.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
RMD assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
RMD liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
RMD debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
RMD balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $1.47B | $1.21B | $238.4M | $227.9M | $273.7M | $295.3M | $463.2M | $147.1M | $188.7M | $821.9M |
| Cash & equivalents | $1.47B | $1.21B | $238.4M | $227.9M | $273.7M | $295.3M | $463.2M | $147.1M | $188.7M | $821.9M |
| Short-term investments | — | $13.1M | $12.0M | $12.4M | $9.2M | — | — | — | $0 | $0 |
| Receivables | $1.04B | $990.7M | $837.3M | $704.9M | $576.0M | $625.2M | $474.6M | $528.5M | $483.7M | $450.5M |
| Inventory | $945.8M | $927.7M | $822.2M | $998.0M | $743.9M | $457.0M | $416.9M | $349.6M | $268.7M | $268.3M |
| Other current assets | $873.5M | $377.8M | $459.8M | $437.0M | $337.9M | $197.3M | $168.7M | $120.1M | $124.6M | $103.2M |
| Total current assets | $4.32B | $3.51B | $2.36B | $2.37B | $1.93B | $1.57B | $1.52B | $1.15B | $1.07B | $1.64B |
| Property, plant & equipment (net) | $735.0M | $718.3M | $699.1M | $665.8M | $630.5M | $592.1M | $535.7M | $387.5M | $386.6M | $394.2M |
| Goodwill & intangible assets | $3.82B | $3.51B | $3.33B | $3.32B | $2.28B | $2.32B | $2.34B | $2.38B | $1.28B | $1.33B |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $52.1M | $41.2M | $38.3M |
| Other non-current assets | $91.2M | $439.0M | $487.6M | $395.4M | $251.5M | $240.8M | $189.7M | $144.4M | $286.3M | $65.2M |
| Total assets | $8.97B | $8.17B | $6.87B | $6.75B | $5.10B | $4.73B | $4.59B | $4.11B | $3.06B | $3.47B |
| Liabilities | ||||||||||
| Accounts payable | $308.9M | $278.2M | $237.7M | $150.8M | $159.2M | $138.0M | $135.8M | $115.7M | $92.7M | $92.8M |
| Short-term debt | $289.1M | $40.4M | $35.2M | $31.8M | $31.8M | $35.6M | $33.2M | $12.0M | $11.5M | $215.0M |
| Deferred revenue | $162.9M | $166.0M | $152.6M | $138.1M | $108.7M | $109.6M | $98.6M | $88.7M | $60.8M | $51.9M |
| Total current liabilities | $1.40B | $1.02B | $910.7M | $758.5M | $689.3M | $911.8M | $602.8M | $556.0M | $511.2M | $360.1M |
| Long-term debt | $399.4M | $658.4M | $697.3M | $1.43B | $765.3M | $643.4M | $1.16B | $1.26B | $270.0M | $1.08B |
| Lease obligations | $166.6M | $183.5M | $166.7M | $138.8M | $142.3M | $138.4M | $123.1M | — | — | — |
| Other long-term liabilities | $586.0M | $529.0M | $400.4M | $432.0M | $280.5M | $287.3M | $323.5M | $220.6M | $223.7M | $69.5M |
| Total liabilities | $2.38B | $2.21B | $2.01B | $2.62B | $1.74B | $1.84B | $2.09B | $2.04B | $1.00B | $1.51B |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $764,000 | $761,000 | $588,000 | $588,000 | $586,000 | $583,000 | $580,000 | $575,000 | $571,000 | $569,000 |
| Retained earnings (deficit) | $7.26B | $6.08B | $4.99B | $4.25B | $3.61B | $3.08B | $2.83B | $2.44B | $2.43B | $2.32B |
| Treasury stock | — | — | — | — | — | −$1.62B | −$1.62B | −$1.62B | −$1.60B | −$1.55B |
| Accumulated other comprehensive income | −$82.5M | −$74.7M | −$251.5M | −$272.5M | −$312.7M | −$193.5M | −$284.0M | −$253.0M | −$224.3M | −$189.1M |
| Total shareholders' equity | $6.59B | $5.97B | $4.86B | $4.13B | $3.36B | $2.89B | $2.50B | $2.07B | $2.06B | $1.96B |
| Key figures | ||||||||||
| Total debt | $825.9M | $851.8M | $873.9M | $1.58B | $917.5M | $793.7M | $1.30B | $1.27B | $281.5M | $1.29B |
| Net cash (debt) | $643.3M | $357.6M | −$635.6M | −$1.35B | −$643.8M | −$498.4M | −$836.1M | −$1.12B | −$92.8M | −$471.7M |
| Working capital | $2.93B | $2.49B | $1.45B | $1.61B | $1.24B | $663.0M | $920.7M | $589.4M | $554.5M | $1.28B |
| Tangible book value | $2.77B | $2.46B | $1.54B | $807.3M | $1.08B | $565.2M | $158.5M | −$306.2M | $774.9M | $633.6M |
| Book value per share | $45.09 | $40.50 | $32.97 | $28.01 | $22.86 | $19.70 | $17.14 | $14.34 | $14.30 | $13.76 |
| Shares outstanding | 146.1M | 147.3M | 147.6M | 147.5M | 147.0M | 146.5M | 145.7M | 144.5M | 144.0M | 142.5M |
| Current ratio | 3.10 | 3.44 | 2.59 | 3.12 | 2.80 | 1.73 | 2.53 | 2.06 | 2.08 | 4.57 |
| Quick ratio | 1.80 | 2.16 | 1.18 | 1.23 | 1.23 | 1.01 | 1.56 | 1.22 | 1.32 | 3.53 |
| Debt / equity | 0.13 | 0.14 | 0.18 | 0.38 | 0.27 | 0.28 | 0.52 | 0.61 | 0.14 | 0.66 |
| Equity / assets | 73.4% | 73.0% | 70.8% | 61.2% | 66.0% | 61.0% | 54.4% | 50.4% | 67.2% | 56.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $1.47B | $1.66B | $1.43B | $1.38B | $1.21B | $944.8M | $521.9M | $426.4M | $238.4M | $237.9M | $210.2M | $209.1M |
| Cash & equivalents | $1.47B | $1.66B | $1.42B | $1.38B | $1.21B | $932.7M | $521.9M | $426.4M | $238.4M | $237.9M | $210.2M | $209.1M |
| Short-term investments | — | $5.5M | $9.3M | $8.0M | $13.1M | $12.1M | — | — | $12.0M | $21.5M | $7.6M | $11.8M |
| Receivables | $1.04B | $1.05B | $1.05B | $958.4M | $990.7M | $939.5M | $959.8M | $811.2M | $875.5M | $779.3M | $764.3M | $692.4M |
| Inventory | $945.8M | $911.9M | $922.0M | $945.8M | $927.7M | $862.6M | $882.1M | $918.0M | $822.2M | $829.5M | $1.13B | $958.2M |
| Other current assets | $873.5M | $445.7M | $423.3M | $337.7M | $377.8M | $461.4M | $472.4M | $485.6M | $421.6M | $504.7M | $273.7M | $444.9M |
| Total current assets | $4.32B | $4.06B | $3.82B | $3.63B | $3.51B | $3.21B | $2.84B | $2.64B | $2.36B | $2.35B | $2.38B | $2.30B |
| Property, plant & equipment (net) | $735.0M | $728.6M | $730.2M | $725.6M | $718.3M | $687.9M | $671.2M | $717.3M | $699.1M | $686.8M | $705.2M | $657.4M |
| Goodwill & intangible assets | $3.82B | $3.47B | $3.47B | $3.49B | $3.51B | $3.28B | $3.24B | $3.36B | $3.33B | $3.34B | $3.39B | $3.38B |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $91.2M | $523.3M | $479.8M | $465.8M | $439.0M | $391.4M | $390.6M | $499.4M | $487.6M | $439.4M | $431.8M | $403.4M |
| Total assets | $8.97B | $8.78B | $8.50B | $8.31B | $8.17B | $7.57B | $7.14B | $7.22B | $6.87B | $6.81B | $6.91B | $6.74B |
| Liabilities | ||||||||||||
| Accounts payable | $308.9M | $273.3M | $250.4M | $266.8M | $278.2M | $222.6M | $220.3M | $249.3M | $237.7M | $177.4M | $202.4M | $177.0M |
| Short-term debt | $289.1M | $289.2M | $289.7M | $289.9M | $40.4M | $38.7M | $37.7M | $38.2M | $35.2M | $34.1M | $34.0M | $31.7M |
| Deferred revenue | $162.9M | $179.3M | $176.1M | $167.8M | $166.0M | $160.4M | $156.5M | $157.2M | $152.6M | $150.8M | $148.9M | $146.7M |
| Total current liabilities | $1.40B | $1.35B | $1.25B | $1.26B | $1.02B | $940.5M | $852.0M | $904.1M | $910.7M | $773.0M | $764.1M | $770.8M |
| Long-term debt | $399.4M | $404.2M | $403.9M | $408.7M | $658.4M | $663.1M | $662.9M | $667.6M | $697.3M | $997.0M | $1.22B | $1.35B |
| Lease obligations | $166.6M | $179.1M | $183.9M | $177.8M | $183.5M | $166.7M | $167.0M | $172.8M | $166.7M | $160.5M | $164.7M | $134.2M |
| Other long-term liabilities | $586.0M | $537.0M | $530.5M | $522.9M | $529.0M | $417.0M | $373.5M | $455.7M | $400.4M | $414.6M | $442.4M | $368.1M |
| Total liabilities | $2.38B | $2.29B | $2.18B | $2.19B | $2.21B | $2.02B | $1.89B | $2.03B | $2.01B | $2.18B | $2.42B | $2.49B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $764,000 | $763,000 | $763,000 | $762,000 | $761,000 | $761,000 | $760,000 | $758,000 | $588,000 | $588,000 | $588,000 | $588,000 |
| Retained earnings (deficit) | $7.26B | $6.96B | $6.65B | $6.34B | $6.08B | $5.78B | $5.49B | $5.23B | $4.99B | $4.77B | $4.54B | $4.40B |
| Accumulated other comprehensive income | −$82.5M | −$24.9M | −$29.9M | −$60.7M | −$74.7M | −$250.9M | −$298.9M | −$132.2M | −$251.5M | −$265.3M | −$208.4M | −$320.1M |
| Total shareholders' equity | $6.59B | $6.49B | $6.32B | $6.12B | $5.97B | $5.55B | $5.25B | $5.20B | $4.86B | $4.63B | $4.48B | $4.25B |
| Key figures | ||||||||||||
| Total debt | $825.9M | $843.2M | $1.00B | $846.4M | $851.8M | $839.8M | $839.7M | $850.2M | $873.9M | $1.17B | $1.39B | $1.50B |
| Net cash (debt) | $643.3M | $817.3M | $424.5M | $537.5M | $357.6M | $105.1M | −$317.8M | −$423.9M | −$635.6M | −$929.5M | −$1.18B | −$1.29B |
| Working capital | $2.93B | $2.71B | $2.57B | $2.37B | $2.49B | $2.27B | $1.98B | $1.74B | $1.45B | $1.58B | $1.61B | $1.53B |
| Tangible book value | $2.77B | $3.02B | $2.85B | $2.63B | $2.46B | $2.27B | $2.01B | $1.83B | $1.54B | $1.29B | $1.09B | $875.0M |
| Book value per share | $45.42 | $44.15 | $42.99 | $41.63 | $40.59 | $37.67 | $35.59 | $35.20 | $32.97 | $31.40 | $30.38 | $28.82 |
| Shares outstanding | 145.0M | 147.0M | 147.0M | 147.0M | 147.0M | 147.2M | 147.6M | 147.6M | 147.5M | 147.4M | 147.5M | 147.5M |
| Current ratio | 3.10 | 3.01 | 3.06 | 2.89 | 3.44 | 3.41 | 3.33 | 2.92 | 2.59 | 3.04 | 3.11 | 2.99 |
| Quick ratio | 1.80 | 2.00 | 1.98 | 1.87 | 2.16 | 2.00 | 1.74 | 1.37 | 1.22 | 1.32 | 1.28 | 1.17 |
| Debt / equity | 0.13 | 0.13 | 0.16 | 0.14 | 0.14 | 0.15 | 0.16 | 0.16 | 0.18 | 0.25 | 0.31 | 0.35 |
| Equity / assets | 73.4% | 73.9% | 74.3% | 73.7% | 73.0% | 73.3% | 73.6% | 71.9% | 70.8% | 67.9% | 64.9% | 63.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed August 13, 2026); data from EODHD.
RMD financial position
At the end of fiscal 2026 (June 30, 2026), ResMed had total assets of $9.0 billion (up 9.7% from a year earlier), total liabilities of $2.4 billion and shareholders' equity of $6.6 billion. It held $1.5 billion in cash and short-term investments against $825.9 million of debt, a net cash position of $643.3 million. Its current ratio was 3.10.
Related: RMD income statement, RMD cash flow statement, RMD key metrics. See the RMD stock overview for the latest quote and news.
RMD balance sheet FAQ
What are ResMed's total assets?
ResMed reported total assets of $9.0 billion at the end of fiscal 2026 (June 30, 2026), compared with $8.2 billion a year earlier.
How much debt does ResMed have?
ResMed had $825.9 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.13.
How much cash does ResMed have?
ResMed held $1.5 billion in cash and short-term investments at the end of fiscal 2026; with $825.9 million of debt that is net cash of $643.3 million.
What is ResMed's book value?
ResMed's shareholders' equity (book value) was $6.6 billion at the end of fiscal 2026, or $45.09 per share.
What is ResMed's current ratio?
ResMed had current assets of $4.3 billion and current liabilities of $1.4 billion, a current ratio of 3.10 (it can cover its short-term obligations).
How much goodwill does ResMed have?
ResMed carried $3.8 billion of goodwill and intangible assets, 42.6% of total assets, at the end of fiscal 2026.